AbCellera to Present at Upcoming Investor Conferences in November
04 Novembre 2022 - 9:05PM
Business Wire
AbCellera (Nasdaq: ABCL) today announced that executives from
the Company will present at the following investor conferences:
- Credit Suisse 31st Annual Healthcare Conference on Wednesday,
November 9, 2022, at 3:50 p.m. Pacific Time (6:50 p.m. Eastern
Time)
- Stifel 2022 Healthcare Conference on Tuesday, November 15,
2022, at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time)
Live audio webcasts of each presentation may be accessed through
links that will be posted on AbCellera's Investor Relations
website. Replays of each webcast will be available through the same
links following the presentations.
About AbCellera Biologics Inc. AbCellera is a technology
company that searches, decodes, and analyzes natural immune systems
to find antibodies that its partners can develop into drugs to
prevent and treat disease. AbCellera partners with drug developers
of all sizes, from large pharmaceutical to small biotechnology
companies, empowering them to move quickly, reduce costs, and
tackle the toughest problems in drug development. For more
information, please visit www.abcellera.com.
Source: AbCellera Biologics Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221104005586/en/
Inquiries Media: Jessica Yingling, Ph.D.;
media@abcellera.com, +1(236)521-6774 Business Development: Murray
McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005 Investor
Relations: Josephine Hellschlienger, Ph.D.; ir@abcellera.com,
+1(778)729-9116
Grafico Azioni AbCellera Biologics (NASDAQ:ABCL)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni AbCellera Biologics (NASDAQ:ABCL)
Storico
Da Lug 2023 a Lug 2024